Read the 14th Cochrane Methods report, providing an overview of the key methodological activities in Cochrane for 2024–2025.

This year, World Evidence-based Healthcare Day is focusing on exchanging information and ideas in creative and collaborative ways.

Cochrane is seeking a public collaborator to help shape a global human papillomavirus (HPV) vaccination campaign to support families in making informed decisions about the HPV vaccine.

Cochrane joined global health leaders at the World Health Summit’s Academic Alliance session on confronting disinformation in the global anti-vaccine discourse. Together, they discussed how disinformation continues to undermine vaccine confidence and threaten public health worldwide.

Join us behind the scenes for reflections, best practices and impact stories from author teams, Geographic Groups, and others involving patients and the public in Cochrane activities. This month we meet Dr. Robby Nieuwlaat from Cochrane Canada.

We are excited to announce the launch of a new application round for Cochrane Thematic Groups, with a dedicated focus on infectious diseases.

October 11th marks International Day of the Girl Child, a day that calls for policies that protect girls’ rights and enable their leadership. Pakistan recently introduced the human papilloma virus (HPV) vaccine for girls, aiming for a 90% vaccination rate. Dr Muhammad Tayyab Qureshi, from Cochrane Pakistan, reflects on the vaccine campaign so far, and the value of investing in girl’s futures.

The World Health Organization has launched the Global Clinical Trials Forum, a global, multi-stakeholder network to strengthen clinical trial environments and infrastructure at national, regional and global levels. Cochrane is pleased to be a member of this initiative.

In this video, Karla shares her vision for creating an evidence ecosystem that is fast, fair and fit for the future, with collaboration at the heart of this. Watch to find out more.

Vaccines for respiratory syncytial virus (RSV) reduce the risk of infection in older adults and infants, a new Cochrane review has found.

Cochrane’s Governing Board is pleased to announce the appointment of Dr Karla Soares-Weiser as the organization’s new Chief Executive Officer.

Our Methods Groups provide policy advice and focus on developing the methods used to produce Cochrane reviews. Over the past year they’ve been working hard on activities from writing papers on responsible AI use to identifying research priorities.

Cochrane is implementing three changes to align review reporting formats for different types of Cochrane reviews.

Heidi learned about Cochrane through her university coursework. Since then, Heidi has been involved in Cochrane Engage opportunities and beyond. Discover her story.

For over 30 years, the Cochrane Collaboration has set the standard for systematic reviews in health research. We now want to take evidence synthesis to the next level.

Cochrane will be attending the 80th session of the United Nations General Assembly (UNGA), taking place in New York from the 21st to the 29th of September 2025.

A new tool to identify problematic trials is now available, enabling researchers to check whether studies are trustworthy before including them in systematic reviews.

With the UK’s National Health Service facing critical workforce shortages, Cochrane Response worked with the Royal College of Anaesthetists to review global evidence on non-physician anaesthesia providers.

The latest update in a Cochrane review finds that tailored exercise programs, vitamin D supplements and dairy-rich diets can help prevent falls in care homes.

Join us behind the scenes for reflections, best practices and impact stories from author teams, Geographic Groups, and others involving patients and the public in Cochrane activities. First up, Cochrane Germany!